Evercore ISI Group Maintains Outperform on Abbott Laboratories, Raises Price Target to $124
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group has maintained an 'Outperform' rating on Abbott Laboratories and raised its price target from $120 to $124.
October 01, 2024 | 4:11 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Evercore ISI Group has maintained an 'Outperform' rating on Abbott Laboratories and increased its price target from $120 to $124, indicating positive sentiment and potential for stock price appreciation.
The 'Outperform' rating suggests that the analyst expects Abbott Laboratories to perform better than the market average. The increase in the price target from $120 to $124 indicates a positive outlook and potential for stock price appreciation, which is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100